Pam Sharma

Padmanee “Pam” Sharma, MD, PhD, Professor of Genitourinary Medical Oncology and Immunology, Co-Director for Immunotherapy at University of Texas MD Anderson Cancer Center. She is a leading cancer immunotherapy translational scientist. She is a Co-Founder of Jounce Therapeutics, a clinical-stage immunotherapy company dedicated to transforming cancer treatment by developing therapies that enable the immune system to attack tumors and provide longterm benefits to patients through a biomarker-driven approach.

A Cancer Research Insitute Investigator, Dr. Sharma has tested new prostate cancer immunotherapies, looking for differences in T cell subsets and function between pre-therapy blood and tissue samples versus post-therapy blood and tissue samples. She is working with Dr. Jim Allison to explore combinations of immunological therapies and targeted drugs in preclinical studies to more effectively treat a variety of cancers.